Joinn Laboratories(China)Co.,Ltd. (6127.HK)
6127.HK Stock Price Chart
Explore Joinn Laboratories(China)Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 6127.HK price movements and trends.
6127.HK Company Profile
Discover essential business fundamentals and corporate details for Joinn Laboratories(China)Co.,Ltd. (6127.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
26 Feb 2021
Employees
2.51K
Website
https://www.joinn-lab.comCEO
Yuxia Feng
Description
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.
6127.HK Financial Timeline
Browse a chronological timeline of Joinn Laboratories(China)Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 26 Aug 2025
EPS came in at $0.03 falling short of the estimated $0.13 by -73.98%, while revenue for the quarter reached $414.33M , missing expectations by -20.22%.
Dividend declared on 26 Jun 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 29 Aug 2025.
Earnings released on 28 Apr 2025
EPS came in at $0.05 falling short of the estimated $0.10 by -50.00%, while revenue for the quarter reached $306.62M , missing expectations by -47.05%.
Earnings released on 26 Mar 2025
EPS came in at $0.19 surpassing the estimated $0.16 by +18.75%, while revenue for the quarter reached $726.76M , missing expectations by -10.52%.
Earnings released on 30 Oct 2024
EPS came in at $0.14 surpassing the estimated $0.09 by +55.56%, while revenue for the quarter reached $537.57M , missing expectations by -40.60%.
Earnings released on 31 Aug 2024
EPS came in at $0.13 falling short of the estimated $0.20 by -35.00%, while revenue for the quarter reached $563.31M , missing expectations by -13.82%.
Dividend declared on 28 Jun 2024
A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 31 Jul 2024.
Earnings released on 29 Apr 2024
EPS came in at -$0.36 falling short of the estimated -$0.03 by -1.30K%, while revenue for the quarter reached $351.41M , missing expectations by -47.56%.
Earnings released on 10 Jan 2024
EPS came in at $0.27 falling short of the estimated $0.32 by -15.62%, while revenue for the quarter reached $873.72M , beating expectations by +0.07%.
Earnings released on 30 Sept 2023
EPS came in at $0.34 surpassing the estimated $0.15 by +133.15%, while revenue for the quarter reached $616.72M , missing expectations by -6.59%.
Earnings released on 31 Aug 2023
EPS came in at -$0.08 falling short of the estimated $0.12 by -166.67%, while revenue for the quarter reached $695.02M , beating expectations by +0.02%.
Dividend declared on 20 Jun 2023
A dividend of $0.67 per share was announced, adjusted to $0.48. The dividend was paid on 20 Jul 2023.
Stock split effective on 20 Jun 2023
Shares were split 7 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2023
EPS came in at $0.82 surpassing the estimated $0.41 by +100.00%, while revenue for the quarter reached $421.65M , missing expectations by -57.32%.
Earnings released on 31 Dec 2022
EPS came in at $0.94 surpassing the estimated $0.24 by +294.12%, while revenue for the quarter reached $1.13B , beating expectations by +135.18%.
Earnings released on 30 Sept 2022
EPS came in at $0.54 surpassing the estimated $0.35 by +55.83%, while revenue for the quarter reached $548.72M , missing expectations by -31.05%.
Earnings released on 31 Aug 2022
EPS came in at $0.54 surpassing the estimated $0.38 by +42.44%, while revenue for the quarter reached $592.24M .
Dividend declared on 28 Jul 2022
A dividend of $0.68 per share was announced, adjusted to $0.35. The dividend was paid on 23 Aug 2022.
Stock split effective on 28 Jul 2022
Shares were split 7 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Apr 2022
EPS came in at $0.29 surpassing the estimated $0.21 by +39.73%, while revenue for the quarter reached $333.95M .
Earnings released on 25 Feb 2022
EPS came in at $0.71 , while revenue for the quarter reached $807.92M .
Earnings released on 31 Oct 2021
EPS came in at $0.24 , while revenue for the quarter reached $388.68M .
Earnings released on 31 Aug 2021
EPS came in at $0.15 , while revenue for the quarter reached $400.49M .
Dividend declared on 23 Jun 2021
A dividend of $0.42 per share was announced, adjusted to $0.18. The dividend was paid on 30 Jul 2021.
Stock split effective on 23 Jun 2021
Shares were split 7 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Apr 2021
EPS came in at $0.16 , while revenue for the quarter reached $238.01M .
Earnings released on 30 Mar 2021
EPS came in at $0.10 , while revenue for the quarter reached $266.99M .
Earnings released on 31 Dec 2020
EPS came in at $0.50 , while revenue for the quarter reached $527.77M .
6127.HK Stock Performance
Access detailed 6127.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.